‌Blood Cancers & Blood Disorders

Blood Cancer

Hans Lee, MD

SCRI, will deliver “First Results from the Phase 1/2 LINKER-AL2 Trial of Linvoseltamab in Patients with Relapsed or Refractory Systemic Light Chain Amyloidosis,” in an oral presentation on Friday, May 29 at 3:09 p.m. CDT during the session, Hematologic Malignancies—Plasma Cell Dyscrasia in S100a.   

Click here to learn more about Dr. Lee